BRETHAIRE Drug Patent Profile
✉ Email this page to a colleague
When do Brethaire patents expire, and when can generic versions of Brethaire launch?
Brethaire is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in BRETHAIRE is terbutaline sulfate. There are seven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the terbutaline sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Brethaire
A generic version of BRETHAIRE was approved as terbutaline sulfate by IMPAX LABS on June 26th, 2001.
Summary for BRETHAIRE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 58 |
Clinical Trials: | 1 |
Patent Applications: | 3,917 |
Formulation / Manufacturing: | see details |
DailyMed Link: | BRETHAIRE at DailyMed |
Recent Clinical Trials for BRETHAIRE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Yaakov Beilin | Phase 2/Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for BRETHAIRE
US Patents and Regulatory Information for BRETHAIRE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | BRETHAIRE | terbutaline sulfate | AEROSOL, METERED;INHALATION | 018762-001 | Aug 17, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BRETHAIRE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | BRETHAIRE | terbutaline sulfate | AEROSOL, METERED;INHALATION | 018762-001 | Aug 17, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
Novartis | BRETHAIRE | terbutaline sulfate | AEROSOL, METERED;INHALATION | 018762-001 | Aug 17, 1984 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for BRETHAIRE
See the table below for patents covering BRETHAIRE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Finland | 54798 | ⤷ Try a Trial | |
Norway | 124723 | ⤷ Try a Trial | |
Spain | 346131 | ⤷ Try a Trial | |
Switzerland | 510626 | Verfahren zur Herstellung von neuen 1-(3',5'-Dihydroxy- bzw. -acyloxy-phenyl)-2-aminoäthanolen und deren physiologisch verträglichen Säureadditionssalzen (1-3 5-dihydroxyphenyl-2-alkylaminoethanols) | ⤷ Try a Trial |
Denmark | 135577 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |